Musa Hindiyeh

Musa Hindiyeh

Auto-generated profile, based on publicly available information

Musa Hindiyeh

Caritas Baby Hospital, Bethlehem, Palestine

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 July 2017 in International Journal of Microbiology
Verified
Journal Article
Open access
PDF file
RHRegeen Handal
Regeen Handal
LQLulu Qunibi
Lulu Qunibi
ISIbrahim Sahouri
Ibrahim Sahouri
MJMaha Juhari
Maha Juhari
RDRula Dawodi
Rula Dawodi
MHMusa Hindiyeh
Musa Hindiyeh
The American Centers for Disease Control and Prevention (CDC) recognizes Acinetobacter baumannii as a source of global outbreaks and epidemics especially due to its increasing resistance to commercially available antibiotics. In this study, 69 single patient multidrug resistant isolates collected from all over Palestine, except Gaza, were studied. All the isolates were resistant to all the β–lactam antibiotics including the carbapenems. Of the 69 isolates, 82.6% were positive for blaOXA-23, 14.5% were positive for blaOXA-24, and 3% were positive for blaOXA-58. None were positive for blaOXA-143 and blaOXA-235. In addition, 5.8% and 0% were positive for blaNDM and blaKPC, respectively. Of the 69 isolates, none were positive for the aminoglycoside aphA6 gene while 93% were positive for the aphA1 gene. The acetyltransferases aacC1 and aacA4 genes tested positive in 22% and 13% of the isolates, respectively. The ompA biofilm-producing virulence gene was detected in all isolates. Finally, Multilocus Sequence Typing (MLST) of 13 isolates revealed that more than one strain of A. baumannii was circulating in Palestinian hospitals as results revealed that 7 isolates were of ST208, 2 isolates ST218, 1 isolate ST231, 1 isolate ST348, and 2 new Sequence Types. The detection of these drug resistant pathogens is a reminder of the importance of active surveillance for resistant bacteria in order to prevent their spread in hospital settings.

1 April 2019 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
PDF file
MSMuna Salah
Muna Salah
ISIssa Shtayeh
Issa Shtayeh
RGRaed Ghneim
Raed Ghneim
RARanda Al-Qass
Randa Al-Qass
ASAli Sabateen
Ali Sabateen
MHMusa Hindiyeh
Musa Hindiyeh
Azithromycin (AZM) has been recommended by the American Academy of Pediatrics for the treatment of shigellosis in children. In this study, 502 Shigella species isolated between 2004 and 2014 were tested for AZM epidemiological cutoff values (ECV) by disk diffusion.

24 July 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ISIssa Siryani
Issa Siryani
MJMohamed Jama
Mohamed Jama
NRNisreen Rumman
Nisreen Rumman
HMHiyam Marzouqa
Hiyam Marzouqa
MKMoein Kannan
Moein Kannan
MHMusa Hindiyeh
Musa Hindiyeh
Cystic fibrosis (CF) is an autosomal recessive inherited life-threatening disorder that causes severe damage to the lungs and the digestive system. In Palestine, mutations in the Cystic Fibrosis Transmembrane Conductance Regulator gene (CFTR) that contributes to the clinical presentation of CF are ill defined. A cohort of thirty three clinically diagnosed CF patients from twenty one different Palestinian families residing in the central and southern part of Palestine were incorporated in this study. Sweat chloride testing was performed using the Sweat Chek Conductivity Analyzer (ELITECH Group, France) to confirm the clinical diagnosis of CF. In addition, nucleic acid from the patients’ blood samples was extracted and the CFTR mutation profiles were assessed by direct sequencing of the CFTR 27 exons and the intron-exon boundaries. For patient’s DNA samples where no homozygous or two heterozygous CFTR mutations were identified by exon sequencing, DNA samples were tested for deletions or duplications using SALSA MLPA probemix P091-D1 CFTR assay. Sweat chloride testing confirmed the clinical diagnosis of CF in those patients. All patients had NaCl conductivity >60mmol/l. In addition, nine different CFTR mutations were identified in all 21 different families evaluated. These mutations were c.1393-1G>A, F508del, W1282X, G85E, c.313delA, N1303K, deletion exons 17a-17b-18, deletion exons 17a-17b and Q1100P. c.1393-1G>A was shown to be the most frequent occurring mutation among tested families. We have profiled the underling mutations in the CFTR gene of a cohort of 21 different families affected by CF. Unlike other studies from the Arab countries where F508del was reported to be the most common mutation, in southern/central Palestine, the c.1393-1G>A appeared to be the most common. Further studies are needed per sample size and geographic distribution to account for other possible CFTR genetic alterations and their frequencies. Genotype/phenotype assessments are also recommended and finally carrier frequency should be ascertained.

1 September 2014 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
HRHandal Regeen
Handal Regeen
DADalia Al-Sharafa-Kittaneh
Dalia Al-Sharafa-Kittaneh
RKRanda Kattan
Randa Kattan
RARula Al-Dawodi
Rula Al-Dawodi
HMHiyam Marzouqa
Hiyam Marzouqa
MHMusa Y. Hindiyeh
Musa Y. Hindiyeh

1 May 2010 in Emerging Infectious Diseases
Verified
Journal Article
Open access
MMMichal Mandelboim
Michal Mandelboim
MHMusa Hindiyeh
Musa Hindiyeh
TMTal Meningher
Tal Meningher
EMElla Mendelson
Ella Mendelson

15 June 2018 in Journal of Public Health
Verified
Journal Article
Closed access
PDF file
WRW P Rennert
W P Rennert
MHM Hindiyeh
M Hindiyeh
FAF M Abu-Awwad
F M Abu-Awwad
HMH Marzouqa
H Marzouqa
ARA Ramlawi
A Ramlawi
Introducing childhood immunization poses challenges in environments of societal fragility. The Palestinian territories (Pt) are considered ‘fragile’ because of their lack of political, economic and territorial sovereignty. Poverty is rife, infant mortality high, and diseases associated with overcrowding widespread. Under these circumstances the Rostropovich Vishneskaya Foundation (RVF) has assembled a network of public and private stakeholders to introduce a country-wide rotavirus immunization program. The incidence of diarrhea was determined for 18 months before and 18 months after the introduction of rotavirus vaccine among all children younger than 5 years presenting to outpatient clinics in Gaza with three or more loose stools per day. Simultaneously the prevalence of rotavirus was established by rotavirus antigen detection in stool samples collected from children younger than 3 years at Caritas Baby Hospital in Bethlehem during the corresponding time periods. Within 12 months 97.4% immunization coverage was achieved. The incidence of diarrhea dropped by 32.2%, while the prevalence of rotavirus in stool samples decreased by 64.6% throughout the following year. In environments of economic or political instability private–public partnerships for the introduction of comprehensive vaccination programs can work based on close collaboration, shared vision, flexibility and inter-organizational trust.